US company Gilead Sciences reports $900m in remdesivir sales
নিউ এইজ
প্রকাশিত: ২৯ অক্টোবর ২০২০, ১১:১৭
Remdesivir, a therapeutic to treat COVID-19, boosted third-quarter sales for pharmaceutical company Gilead Sciences by nearly $900 million, according to results released Wednesday by the...